Respiratory drug market dynamics

Nature Reviews Drug Discovery

Volumn 6, Issue 9, 2007, Pages 695-696

  Oversteegen, Lisette ^a   Rovini, Holger ^a   Belsey, Mark J ^b  

^a Datamonitor Healthcare   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ASM 8; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CXCR ANTAGONIST; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; IMMUNOGLOBULIN E; LONG ACTING DRUG; MONTELUKAST; MUSCARINIC AGENT; OLIGONUCLEOTIDE; OMALIZUMAB; PHOSPHODIESTERASE IV INHIBITOR; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HUMAN; LUNG FUNCTION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; TREND STUDY;

DRUG INDUSTRY; MARKETING; RESPIRATORY SYSTEM AGENTS;

EID: 34548311942     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2401     Document Type: Article

References (7)

1. The seven major markets comprise of the five major European markets (France, Germany, Italy, Spain and the UK), Japan and the US.
2. Fleming, D. M., Sunderland, R., Cross, K. W. & Ross, A. M. Declining incidence of episodes of asthma: A study of trends in new episodes presenting to general practitioners in the period 1989-98. Thorax 55, 657-661 (2000).
3. Hoare, J., Bruce, M. & Majeed, A. Prevalence of treated asthma and its management in general practice in England and Wales, 1994-1998. Health Stat. Q. 17, 15-22 (2003).
4. Vandevoorde, J. et al. Early detection of COPD: A case finding study in general practice. Respir. Med. 101, 525-530 (2007).
5. MIDAS Sales Data, IMS Health, April 2007.
6. IMS Health. Leading Products by Global Pharmaceutical Sales, 2006. IMS Health web site [online], (2006).
7. Adams, C. P., Branter, V. V. Estimating the cost of new drug development: Is it really 802 million dollars? Health Aff. 25 420-428 (2006).